Premium
Pregnancy after fertility‐sparing surgery for borderline ovarian tumors
Author(s) -
Lian Chengying,
Chen Xiujuan,
Ni Yihua,
Huang Xiaochen,
Lin Yuan
Publication year - 2016
Publication title -
international journal of gynecology and obstetrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.895
H-Index - 97
eISSN - 1879-3479
pISSN - 0020-7292
DOI - 10.1016/j.ijgo.2016.03.018
Subject(s) - medicine , pregnancy , infertility , fertility , endometriosis , retrospective cohort study , gynecology , obstetrics , pregnancy rate , fertility preservation , pelvic inflammatory disease , stage (stratigraphy) , population , surgery , paleontology , genetics , environmental health , biology
Objective To investigate the ability to conceive and the factors affecting chances of pregnancy among patients with borderline ovarian tumors (BOTs) treated with fertility‐sparing surgery. Methods A retrospective study included nulliparous patients aged 40 years or younger who had undergone fertility‐sparing surgery for BOTs between January 2005 and June 2012 at a center in Fuzhou, China. Identified patients were followed up by telephone or mail between March 15 and June 30, 2013. Patients who had already been pregnant and those who had not but had discontinued contraception for more than 1 year were included in final analyses. Results Among 23 included patients, 17 (74%) had become pregnant within the mean follow‐up period of 48.2 months. The frequencies of previous infertility, sequelae of pelvic inflammatory disease, and endometriosis were all higher in the nonpregnant group than in the pregnant group ( P ≤ 0.021 for all). More women in the nonpregnant group that in the pregnant group had BOTs of stage II or worse, but the difference was nonsignificant ( P = 0.059). Conclusion Fertility‐sparing surgery in young patients with BOTs is associated with a good pregnancy rate. However, the tumor stage and coexisting infertility factors are important considerations in selecting the optimal surgical approach.